Clinical Trial Update: Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating a neoantigen-pulsed autologous dendritic cell vaccine in combination with temozolomide for newly d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Neoantigen-Pulsed Autologous Dendritic Cell Vaccine
• Temozolomide (Temozolomide)

Snippet

Sponsor: ZSky Biotech Inc | Conditions: Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING